Researchers evaluated the contribution of abnormal GI transit to systemic sclerosis Medsger GI severity scores and/or UCLA GIT 2.0 symptoms. Delayed transit in the small bowel and colon were found to ...

Every rheumatologist ought to be comfortable in using a validated gastrointestinal symptom scale for evaluation of gastroesophageal reflux disease in patients with scleroderma, Tracy M. Frech, MD, ...

Background Systemic sclerosis (SSc) is a chronic autoimmune disease characterised by microvascular damage and fibrosis. Mortality in patients with SSc has significantly decreased. Consequently, ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Stepwise interventions, starting with diet and moving on to pharmacotherapies in more severe ...

Please provide your email address to receive an email when new articles are posted on . Scleroderma and other connective tissue diseases such as systemic lupus erythematosis, dermatomyositis, Behçet’s ...

ABSTRACT: Background and Aims: Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by widespread fibrosis and vascular abnormalities that affect multiple organs, including the ...

ATLANTA - New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found no clear association between immunosuppressive or anti-fibrotic ...

Scleroderma is a rare and complex autoimmune disease that leads to the tightening and hardening of the skin and connective tissues. This condition, also known as systemic sclerosis, results from the ...